Advocacy intelligence hub — real-time data for patient organizations
City of Hope Medical Center — PHASE1
The Affiliated Hospital of Xuzhou Medical University — PHASE2
SecuraBio — PHASE3
The Affiliated Hospital of Xuzhou Medical University — PHASE2
Memorial Sloan Kettering Cancer Center — PHASE2
Arvinas Inc. — PHASE1
Regeneron Pharmaceuticals — PHASE3
Zhengzhou University — PHASE4
Janssen Research & Development, LLC — PHASE1
Regeneron Pharmaceuticals — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Julie M Vose, OTR/L
University of Nebraska
📍 MANCHESTER, NH
Eric Jacobsen, MD
Dana-Farber Cancer Institute
Paolo Caimi, MD, M.D
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
📍 CLEVELAND, OH
Thomas G. Martin, MD
University of California, San Francisco
Jonathan Moreira, MD, MD
Northwestern University
📍 CHICAGO, IL